Real World Study to Describe the Effectiveness and Safety of Teprotumumab Among Thyroid Eye Disease Patients

by | Jul 25, 2025 | Clinical Trials | 0 comments

​ Conditions: Thyroid Eye Disease

Interventions: Drug: Teprotumumab

Sponsors: Amgen

Recruiting Conditions: Thyroid Eye Disease
Interventions: Drug: Teprotumumab
Sponsors: Amgen
Recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *